Changes of circulating atrial natriuretic peptide and antidiuretic hormone in obstructive sleep apnea syndrome.
Patients with obstructive sleep apnea (OSA) syndrome are known to exhibit nocturnal natriuresis/diuresis. We studied plasma and urinary levels of atrial natriuretic peptide (ANP), a potent natriuretic hormone released from the heart, and plasma antidiuretic hormone (ADH) levels in patients with OSA during awake and sleeping periods, to compare with those of normal subjects. Seven patients with OSA and 6 normal subjects were studied. Arterial blood samples were drawn during the awake and the sleeping period, while in patients with OSA, blood samples were obtained during the apneic period. Urine samples were collected over two 12-hour periods (9 a.m.-9 p.m. and 9 p.m.-9 a.m.) In patients with OSA, plasma ANP as well as urinary ANP excretion increased during the apneic period compared with the awake period. There was a significant negative correlation between plasma levels of ANP and ADH in patients with OSA. On the other hand, normal subjects had no apparent differences in plasma and urinary ANP levels between the two periods. It is suggested that nocturnal increase in ANP and decrease in ADH are responsible for the nocturnal diuresis and natriuresis associated with OSA.
Ichioka
M
M
Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.
Hirata
Y
Y
Inase
N
N
Tojo
N
N
Yoshizawa
M
M
Chida
M
M
Miyazato
I
I
Taniai
S
S
Marumo
F
F
D000328:Adult; D009320:Atrial Natriuretic Factor / Q000097:blood* / Q000652:urine; D016022:Case-Control Studies; D002940:Circadian Rhythm / Q000502:physiology; D004231:Diuresis / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012890:Sleep / Q000502:physiology; D012891:Sleep Apnea Syndromes / Q000097:blood* / Q000503:physiopathology / Q000652:urine; D014667:Vasopressins / Q000097:blood*
D014667:Vasopressins; D009320:Atrial Natriuretic Factor